Remove Article Remove Communication Remove Compounding Remove Pharmaceutical Companies
article thumbnail

Adapting Customer Engagement Strategies to the COVID Landscape

Pharma Marketing Network

In office/in person sales promotion, the staple of pharmaceutical company activities, is simply not possible today with interactions reduced to the sporadic video or to telephone engagement. Understanding how to modify communication style is a first step.

article thumbnail

The Best Probiotics for Hashimoto’s

The Thyroid Pharmacist

Discovering the right type of probiotics was an important part of healing my own gut, and in this article, I’d like to share more information about: The root causes of intestinal permeability. I am excited that new research about the Hashimoto’s and microbiome connection has come out since I published Hashimoto’s: The Root Cause.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What to Keep in Your Integrative Medicine Cabinet

The Thyroid Pharmacist

I started talking to Carter Black, RPh, my compounding pharmacist, about the symptoms I was experiencing, and he suggested that I have my adrenals tested. 3] You can learn more about the HPA axis and adrenals here in the linked article. Garlic Oil Garlic is another natural compound that provides a host of health benefits.

article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements.

article thumbnail

Challenges for Net Zero Carbon Pharmaceutical Manufacturing

ISPE

link] A recent study published by My Green Lab 2 presented data from 74 biotechnology and pharmaceutical companies tracking the change in scope 1, 2, and 3 carbon intensity (measured in tons of CO2 emitted vs. the company’s revenue in USD) since 2015. For pharmaceutical companies, purchased goods (e.g.,